181 related articles for article (PubMed ID: 18794669)
21. Safety and tolerability of duloxetine in elderly patients with major depressive disorder: a pooled analysis of two placebo-controlled studies.
Oakes TM; Katona C; Liu P; Robinson M; Raskin J; Greist JH
Int Clin Psychopharmacol; 2013 Jan; 28(1):1-11. PubMed ID: 23138680
[TBL] [Abstract][Full Text] [Related]
22. An open, non-randomised comparison of escitalopram and duloxetine for the treatment of subjects with Generalized Anxiety Disorder.
PierĂ² A; Locati E
Hum Psychopharmacol; 2011 Jan; 26(1):63-71. PubMed ID: 21305612
[TBL] [Abstract][Full Text] [Related]
23. False conclusions regarding duloxetine's purported efficacy in pain among depressed patients.
Spielmans GI
Psychiatr Danub; 2010 Dec; 22(4):550; author reply 551. PubMed ID: 21169898
[No Abstract] [Full Text] [Related]
24. Duloxetine hydrochloride.
Waitekus AB; Kirkpatrick P
Nat Rev Drug Discov; 2004 Nov; 3(11):907-8. PubMed ID: 15558861
[No Abstract] [Full Text] [Related]
25. Escitalopram and duloxetine in the treatment of major depressive disorder: a pooled analysis of two trials.
Lam RW; Andersen HF; Wade AG
Int Clin Psychopharmacol; 2008 Jul; 23(4):181-7. PubMed ID: 18545055
[TBL] [Abstract][Full Text] [Related]
26. An open-label study of duloxetine hydrochloride, a mixed serotonin and noradrenaline reuptake inhibitor, in patients with DSM-III-R major depressive disorder. Lilly Duloxetine Depression Study Group.
Berk M; du Plessis AD; Birkett M; Richardt D
Int Clin Psychopharmacol; 1997 May; 12(3):137-40. PubMed ID: 9248869
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and tolerability of duloxetine, a novel dual reuptake inhibitor, in the treatment of major depressive disorder.
Schatzberg AF
J Clin Psychiatry; 2003; 64 Suppl 13():30-7. PubMed ID: 14552654
[TBL] [Abstract][Full Text] [Related]
28. Is there a place for duloxetine?
Drug Ther Bull; 2007 Apr; 45(4):29-32. PubMed ID: 17451072
[TBL] [Abstract][Full Text] [Related]
29. Duloxetine: a dual reuptake inhibitor.
Dugan SE; Fuller MA
Ann Pharmacother; 2004 Dec; 38(12):2078-85. PubMed ID: 15522980
[TBL] [Abstract][Full Text] [Related]
30. Use of duloxetine in patients with an anxiety disorder, or with comorbid anxiety and major depressive disorder: a review of the literature.
Mancini M; Perna G; Rossi A; Petralia A
Expert Opin Pharmacother; 2010 May; 11(7):1167-81. PubMed ID: 20402555
[TBL] [Abstract][Full Text] [Related]
31. Duloxetine in major depressed patients resistant to SSRIs and/or venlafaxine.
Pitchot W; Scantamburlo G; Ansseau M
Psychiatr Danub; 2010 Nov; 22 Suppl 1():S106-7. PubMed ID: 21057413
[TBL] [Abstract][Full Text] [Related]
32. Clinical outcome and tolerability of duloxetine in the treatment of major depressive disorder: a 12-week study with plasma levels.
Volonteri LS; Colasanti A; Cerveri G; Fiorentini A; De Gaspari IF; Mauri MC; Valli A; Papa P; Mencacci C
J Psychopharmacol; 2010 Aug; 24(8):1193-9. PubMed ID: 19406851
[TBL] [Abstract][Full Text] [Related]
33. [FDA approval for the antidepressive drug Cymbalta].
Krankenpfl J; 2004; 42(5-6):154. PubMed ID: 15527218
[No Abstract] [Full Text] [Related]
34. Successful treatment of refractory hypochondriasis with duloxetine.
Politi P; Emanuele E
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1145-6. PubMed ID: 17493731
[No Abstract] [Full Text] [Related]
35. The treatment of urinary incontinence with Duloxetine.
Basu M; Duckett J
J Obstet Gynaecol; 2008 Feb; 28(2):166-9. PubMed ID: 18393011
[TBL] [Abstract][Full Text] [Related]
36. Duloexetine (Cymbalta) for treatment of major depressive disorder.
Cobb C; Crichlow R
Am Fam Physician; 2005 Sep; 72(6):1099-101. PubMed ID: 16190509
[No Abstract] [Full Text] [Related]
37. Physical symptoms comorbid with depression and the new antidepressant duloxetine.
Bailey KP
J Psychosoc Nurs Ment Health Serv; 2003 Dec; 41(12):13-8. PubMed ID: 14682027
[TBL] [Abstract][Full Text] [Related]
38. Open-label support for duloxetine for the treatment of panic disorder.
Simon NM; Kaufman RE; Hoge EA; Worthington JJ; Herlands NN; Owens ME; Pollack MH
CNS Neurosci Ther; 2009; 15(1):19-23. PubMed ID: 19228176
[TBL] [Abstract][Full Text] [Related]
39. Duloxetine treatment of Premenstrual Dysphoric Disorder: case reports.
Ramos MG; Hara C; Rocha FL
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):579-80. PubMed ID: 17897763
[No Abstract] [Full Text] [Related]
40. Initial duloxetine prescription dose and treatment adherence and persistence in patients with major depressive disorder.
Liu X; Gelwicks S; Faries DE; Able SL
Int Clin Psychopharmacol; 2010 Nov; 25(6):315-22. PubMed ID: 20706125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]